AltMountain

Sosv Ireland Biomanufacturing Fund LP

Princeton, NJ · CIK 2012879
Emerging

Sosv Ireland Biomanufacturing Fund LP is a venture capital fund based in Princeton, New Jersey. According to its most recent Form D, filed Oct 3, 2025, it has sold $20,800,000 of interests to 4 investors since its first sale in Mar 2024. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include General Partner Sosv Ireland Biomanufacturing Fund GP LLC; Sean O'Sullivan.

Total raised
$20,800,000Cumulative sales reported on Form D
Investors
4
First sale
Mar 27, 2024
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
General Partner Sosv Ireland Biomanufacturing Fund GP LLC; Sean O'Sullivan
Latest Form D
Oct 3, 2025

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​‌⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Oct 3, 2025Form D/A (amendment)$20,800,0004SEC.gov ↗
Mar 25, 2024Form D$00SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Mar 25, 2024. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Sosv Ireland Biomanufacturing Fund LP

What is the minimum investment for Sosv Ireland Biomanufacturing Fund LP?

Sosv Ireland Biomanufacturing Fund LP's latest Form D, filed Oct 3, 2025, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Sosv Ireland Biomanufacturing Fund LP?

Sosv Ireland Biomanufacturing Fund LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Sosv Ireland Biomanufacturing Fund LP raised?

Sosv Ireland Biomanufacturing Fund LP reports $20,800,000 sold from 4 investors on its Form D filed Oct 3, 2025. This is cumulative sales since the offering began, not current assets or performance.

Where is Sosv Ireland Biomanufacturing Fund LP based?

Sosv Ireland Biomanufacturing Fund LP is based in Princeton, New Jersey.

When did Sosv Ireland Biomanufacturing Fund LP launch?

Sosv Ireland Biomanufacturing Fund LP reports its first sale in Mar 2024, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).

Size compared with every venture capital fund

Raised more than 90% of the 88 venture capital funds based in New Jersey, and more than 92% of all 14,877 that report sales.

Other funds with the same team

More venture capital funds in Princeton

Similar-size venture capital funds in New Jersey

All venture capital funds in New Jersey